Literature DB >> 11962336

Molecular diagnosis of facioscapulohumeral muscular dystrophy.

Meena Upadhyaya1, David N Cooper.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is the third most common inherited neuromuscular disorder after Duchenne muscular dystrophy and myotonic dystrophy. The gene underlying FSHD was mapped to chromosome 4q35 in 1990 and was shown to be closely linked to locus D4F104S1. Although D4F104S1-associated deletions are closely associated with FSHD, the identity and location of the FSHD gene (or genes) still remain elusive, as does the mechanistic basis of the disease. In addition, although approximately 5% of FSHD families fail to exhibit linkage to 4q35, a putative second locus remains unidentified. The search for the FSHD gene has been hampered both by sequence homologies between the 4q35 candidate region and other chromosomal regions and by the presence of many highly repetitive sequences. Molecular diagnosis for FSHD is usually offered with 98% accuracy but because of its complexity, a much more simple test would be preferable. Indeed, the identification of the FSHD gene itself should potentiate major improvements in diagnostic testing.

Entities:  

Mesh:

Year:  2002        PMID: 11962336     DOI: 10.1586/14737159.2.2.160

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  9 in total

1.  Cytogenetic and immuno-FISH analysis of the 4q subtelomeric region, which is associated with facioscapulohumeral muscular dystrophy.

Authors:  Fan Yang; Chunbo Shao; Vettaikorumakankav Vedanarayanan; Melanie Ehrlich
Journal:  Chromosoma       Date:  2004-05-11       Impact factor: 4.316

2.  Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI.

Authors:  David B Olsen; Peter Gideon; Tina Dysgaard Jeppesen; John Vissing
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

3.  [Facioscapulohumeral muscle dystrophy and heart disease].

Authors:  P Emmrich; V Ogunlade; T Gradistanac; S Daneschnejad; M C Koch; R Schober
Journal:  Z Kardiol       Date:  2005-05

4.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

5.  Muscle MRI findings in facioscapulohumeral muscular dystrophy.

Authors:  Simonetta Gerevini; Marina Scarlato; Lorenzo Maggi; Mariangela Cava; Giandomenico Caliendo; Barbara Pasanisi; Andrea Falini; Stefano Carlo Previtali; Lucia Morandi
Journal:  Eur Radiol       Date:  2015-06-27       Impact factor: 5.315

6.  RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA.

Authors:  Vassilios Alexiadis; Mary E Ballestas; Cecilia Sanchez; Sara Winokur; Vettaikorumakankav Vedanarayanan; Mary Warren; Melanie Ehrlich
Journal:  Biochim Biophys Acta       Date:  2006-11-22

7.  [Multilocular Paget's disease in IBMPFD syndrome. A case report with 14-year follow-up].

Authors:  D Zajonz; C Langsieb; L Chavdarova; S Kellermann; P Baum; C Wickenhauser; G von Salis-Soglio; T Prietzel
Journal:  Orthopade       Date:  2012-06       Impact factor: 1.087

8.  Facioscapulohumeral dystrophy: case report and discussion.

Authors:  Vincenzo Castellano; Joseph Feinberg; Jennifer Michaels
Journal:  HSS J       Date:  2008-07-01

9.  Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.

Authors:  G Ricci; M Zatz; R Tupler
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.